• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    7.86 0.25(3.29%) Dec 26, 4:00PM EST
    Add to Portfolio
    Prev Close:7.61
    Open:7.68
    Bid:N/A
    Ask:8.50 x 900
    1y Target Est:8.00
    Beta:0.63
    Earnings Date:Mar 2 - Mar 6 (Est.)
    Day's Range:7.64 - 7.90
    52wk Range:7.22 - 10.26
    Volume:1,682,423
    Avg Vol (3m):2,770,480
    Market Cap:1.26B
    P/E (ttm):3.99
    EPS (ttm):1.97
    Div & Yield:0.60 (7.90%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PDLI

    Comparison

    Symbol% ChgMkt Cap
    PDLIUp 3.29%1.26B
    AMGN124.34B
    SGEN3.96B
    XOMA397.36M

    Key Statistics

    Forward P/E (1 yr):3.69
    P/S (ttm):2.63
    Ex-Dividend Date:03-Dec-14

    Analysts

    Annual EPS Est (Dec-14) :2.14
    Quarterly EPS Est (Dec-14) :0.57
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.25

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback